Analyst Expectations For Agilent Technologies's Future

Agilent Technologies (NYSE:A) underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

In the assessment of 12-month price targets, analysts unveil insights for Agilent Technologies, presenting an average target of $141.0, a high estimate of $163.00, and a low estimate of $125.00. This current average has decreased by 3.75% from the previous average price target of $146.50.

Diving into Analyst Ratings: An In-Depth Exploration

In examining recent analyst actions, we gain insights into how financial experts perceive Agilent Technologies. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Agilent Technologies. This information offers a snapshot of how analysts perceive the current state of the company.
• Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Agilent Technologies compared to the broader market.
• Price Targets: Understanding forecasts, analysts offer estimates for Agilent Technologies's future value. Examining the current and prior targets provides insight into analysts' changing expectations.

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Agilent Technologies's market standing. Stay informed and make well-considered decisions with our Ratings Table.

Stay up to date on Agilent Technologies analyst ratings.

Discovering Agilent Technologies: A Closer Look

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Agilent Technologies: A Financial Overview

Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.

Revenue Challenges: Agilent Technologies's revenue growth over 3 months faced difficulties. As of 30 April, 2024, the company experienced a decline of approximately -8.39%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.

Net Margin: Agilent Technologies's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 19.58%, the company showcases strong profitability and effective cost management.

Return on Equity (ROE): Agilent Technologies's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.97%, the company showcases efficient use of equity capital and strong financial health.

Return on Assets (ROA): Agilent Technologies's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.83% ROA, the company effectively utilizes its assets for optimal returns.

Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.41.

Analyst Ratings: What Are They?

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

This article was generated by Benzinga's automated content engine and reviewed by an editor.